There is discussion by a lot of doctors that there might be a chance that those vaccinated people can spread the vaccine through there body by shedding through skin and breathing etc ..... apparently the ‘spiked protein’ in the vaccine has been found in people’s saliva, sweat, etc....
So yes there is a good chance that someone vaccinated could spread the mRNA in the vaccine to people who have not been vaccinated....
8.3.5.1. Exposure During Pregnancy
An EDP occurs if:
• A female participant is found to be pregnant while receiving or after discontinuing
study intervention.
• A male participant who is receiving or has discontinued study intervention exposes a
female partner prior to or around the time of conception.
• A female is found to be pregnant while being exposed or having been exposed to
study intervention due to environmental exposure. Below are examples of
environmental exposure during pregnancy:
• A female family member or healthcare provider reports that she is pregnant after
having been exposed to the study intervention by inhalation or skin contact.
• A male family member or healthcare provider who has been exposed to the study
intervention by inhalation or skin contact then exposes his female partner prior to
or around the time of conception.
The investigator must report EDP to Pfizer Safety within 24 hours of the investigator’s
awareness, irrespective of whether an SAE has occurred. The initial information submitted
should include the anticipated date of delivery (see below for information related to
termination of pregnancy).
• If EDP occurs in a participant or a participant’s partner, the investigator must report
this information to Pfizer Safety on the Vaccine SAE Report Form and an EDP
Supplemental Form, regardless of whether an SAE has occurred. Details of the
pregnancy will be collected after the start of study intervention and until 6 months
after the last dose of study intervention.
• If EDP occurs in the setting of environmental exposure, the investigator must report
information to Pfizer Safety using the Vaccine SAE Report Form and EDP
Supplemental Form. Since the exposure information does not pertain to the
participant enrolled in the study, the information is not recorded on a CRF; however,
a copy of the completed Vaccine SAE Report Form is maintained in the investigator
site file.
Follow-up is conducted to obtain general information on the pregnancy and its outcome for
all EDP reports with an unknown outcome. The investigator will follow the pregnancy until
completion (or until pregnancy termination) and notify Pfizer Safety of the outcome as a
follow-up to the initial EDP Supplemental Form. In the case of a live birth, the structural
integrity of the neonate can be assessed at the time of birth. In the event of a termination, the
reason(s) for termination should be specified and, if clinically possible, the structural
integrity of the terminated fetus should be assessed by gross visual inspection (unless
preprocedure test findings are conclusive for a congenital anomaly and the findings are
reported).
Abnormal pregnancy outcomes are considered SAEs. If the outcome of the pregnancy meets
the criteria for an SAE (ie, ectopic pregnancy, spontaneous abortion, intrauterine fetal
demise, neonatal death, or congenital anomaly), the investigator should follow the procedures
for reporting SAEs. Additional information about pregnancy outcomes that are reported to
Pfizer Safety as SAEs follows:
• Spontaneous abortion including miscarriage and missed abortion;
• Neonatal deaths that occur within 1 month of birth should be reported, without regard
to causality, as SAEs. In addition, infant deaths after 1 month should be reported as
SAEs when the investigator assesses the infant death as related or possibly related to
exposure to the study intervention.
Additional information regarding the EDP may be requested by the sponsor. Further
follow-up of birth outcomes will be handled on a case-by-case basis (eg, follow-up on
preterm infants to identify developmental delays). In the case of paternal exposure, the
investigator will provide the participant with the Pregnant Partner Release of Information
Form to deliver to his partner. The investigator must document in the source documents that
the participant was given the Pregnant Partner Release of Information Form to provide to his
partner.
8.3.5.2. Exposure During Breastfeeding
An exposure during breastfeeding occurs if:
• A female participant is found to be breastfeeding while receiving or after
discontinuing study intervention.
• A female is found to be breastfeeding while being exposed or having been exposed to
study intervention (ie, environmental exposure). An example of environmental
exposure during breastfeeding is a female family member or healthcare provider who
reports that she is breastfeeding after having been exposed to the study intervention
by inhalation or skin contact.
The investigator must report exposure during breastfeeding to Pfizer Safety within 24 hours
of the investigator’s awareness, irrespective of whether an SAE has occurred. The
information must be reported using the Vaccine SAE Report Form. When exposure during
breastfeeding occurs in the setting of environmental exposure, the exposure information does
not pertain to the participant enrolled in the study, so the information is not recorded on a
CRF. However, a copy of the completed Vaccine SAE Report Form is maintained in the
investigator site file.
An exposure during breastfeeding report is not created when a Pfizer drug specifically
approved for use in breastfeeding women (eg, vitamins) is administered in accord with
authorized use. However, if the infant experiences an SAE associated with such a drug, the
SAE is reported together with the exposure during breastfeeding.
8.3.5.3. Occupational Exposure
An occupational exposure occurs when a person receives unplanned direct contact with the
study intervention, which may or may not lead to the occurrence of an AE. Such persons
may include healthcare providers, family members, and other roles that are involved in the
trial participant’s care.
The investigator must report occupational exposure to Pfizer Safety within 24 hours of the
investigator’s awareness, regardless of whether there is an associated SAE. The information
must be reported using the Vaccine SAE Report Form. Since the information does not
pertain to a participant enrolled in the study, the information is not recorded on a CRF;
however, a copy of the completed Vaccine SAE Report Form is maintained in the
investigator site file.
Thank you all for the replies. After reading your post Juju7 it only further cemented my decision to not be around my brother. I'm making the 5.5 hr drive to drop off my mother ( he's driving her the rest of the way home to visit with her) and turning right around to head home. God bless you
I wouldnt let the vaccine get in the way of your relationships but if you feel its what's best for you then do what feels best. This document could cause fear in people and I dont believe fear should be the grounds for our decisions.
If this document if true it seems women are at risk and if you have woman in your life and plan on having children in your future then caution should be taken.
Considering its stored in your DNA and you shed 0.03 to 0.09 grams every hour of your skin and have a new outer skin layer after 4-6 weeks. I'm staying away from anyone vaccinated to avoid their potential covid shed for at least 6-8 weeks.
There is discussion by a lot of doctors that there might be a chance that those vaccinated people can spread the vaccine through there body by shedding through skin and breathing etc ..... apparently the ‘spiked protein’ in the vaccine has been found in people’s saliva, sweat, etc....
So yes there is a good chance that someone vaccinated could spread the mRNA in the vaccine to people who have not been vaccinated....
WWG1WGA
I came across this document from pfizer....on page 67 under "8.3.5.1. Exposure During Pregnancy" they mention exposure by "inhalation or skin contact"
Here is the document https://media.tghn.org/medialibrary/2020/11/C4591001_Clinical_Protocol_Nov2020_Pfizer_BioNTech.pdf
8.3.5.1. Exposure During Pregnancy An EDP occurs if: • A female participant is found to be pregnant while receiving or after discontinuing study intervention. • A male participant who is receiving or has discontinued study intervention exposes a female partner prior to or around the time of conception. • A female is found to be pregnant while being exposed or having been exposed to study intervention due to environmental exposure. Below are examples of environmental exposure during pregnancy: • A female family member or healthcare provider reports that she is pregnant after having been exposed to the study intervention by inhalation or skin contact. • A male family member or healthcare provider who has been exposed to the study intervention by inhalation or skin contact then exposes his female partner prior to or around the time of conception. The investigator must report EDP to Pfizer Safety within 24 hours of the investigator’s awareness, irrespective of whether an SAE has occurred. The initial information submitted should include the anticipated date of delivery (see below for information related to termination of pregnancy). • If EDP occurs in a participant or a participant’s partner, the investigator must report this information to Pfizer Safety on the Vaccine SAE Report Form and an EDP Supplemental Form, regardless of whether an SAE has occurred. Details of the pregnancy will be collected after the start of study intervention and until 6 months after the last dose of study intervention. • If EDP occurs in the setting of environmental exposure, the investigator must report information to Pfizer Safety using the Vaccine SAE Report Form and EDP Supplemental Form. Since the exposure information does not pertain to the participant enrolled in the study, the information is not recorded on a CRF; however, a copy of the completed Vaccine SAE Report Form is maintained in the investigator site file. Follow-up is conducted to obtain general information on the pregnancy and its outcome for all EDP reports with an unknown outcome. The investigator will follow the pregnancy until completion (or until pregnancy termination) and notify Pfizer Safety of the outcome as a follow-up to the initial EDP Supplemental Form. In the case of a live birth, the structural integrity of the neonate can be assessed at the time of birth. In the event of a termination, the reason(s) for termination should be specified and, if clinically possible, the structural integrity of the terminated fetus should be assessed by gross visual inspection (unless preprocedure test findings are conclusive for a congenital anomaly and the findings are reported). Abnormal pregnancy outcomes are considered SAEs. If the outcome of the pregnancy meets the criteria for an SAE (ie, ectopic pregnancy, spontaneous abortion, intrauterine fetal demise, neonatal death, or congenital anomaly), the investigator should follow the procedures for reporting SAEs. Additional information about pregnancy outcomes that are reported to Pfizer Safety as SAEs follows: • Spontaneous abortion including miscarriage and missed abortion; • Neonatal deaths that occur within 1 month of birth should be reported, without regard to causality, as SAEs. In addition, infant deaths after 1 month should be reported as SAEs when the investigator assesses the infant death as related or possibly related to exposure to the study intervention. Additional information regarding the EDP may be requested by the sponsor. Further follow-up of birth outcomes will be handled on a case-by-case basis (eg, follow-up on preterm infants to identify developmental delays). In the case of paternal exposure, the investigator will provide the participant with the Pregnant Partner Release of Information Form to deliver to his partner. The investigator must document in the source documents that the participant was given the Pregnant Partner Release of Information Form to provide to his partner. 8.3.5.2. Exposure During Breastfeeding An exposure during breastfeeding occurs if: • A female participant is found to be breastfeeding while receiving or after discontinuing study intervention. • A female is found to be breastfeeding while being exposed or having been exposed to study intervention (ie, environmental exposure). An example of environmental exposure during breastfeeding is a female family member or healthcare provider who reports that she is breastfeeding after having been exposed to the study intervention by inhalation or skin contact. The investigator must report exposure during breastfeeding to Pfizer Safety within 24 hours of the investigator’s awareness, irrespective of whether an SAE has occurred. The information must be reported using the Vaccine SAE Report Form. When exposure during breastfeeding occurs in the setting of environmental exposure, the exposure information does not pertain to the participant enrolled in the study, so the information is not recorded on a CRF. However, a copy of the completed Vaccine SAE Report Form is maintained in the investigator site file. An exposure during breastfeeding report is not created when a Pfizer drug specifically approved for use in breastfeeding women (eg, vitamins) is administered in accord with authorized use. However, if the infant experiences an SAE associated with such a drug, the SAE is reported together with the exposure during breastfeeding. 8.3.5.3. Occupational Exposure An occupational exposure occurs when a person receives unplanned direct contact with the study intervention, which may or may not lead to the occurrence of an AE. Such persons may include healthcare providers, family members, and other roles that are involved in the trial participant’s care. The investigator must report occupational exposure to Pfizer Safety within 24 hours of the investigator’s awareness, regardless of whether there is an associated SAE. The information must be reported using the Vaccine SAE Report Form. Since the information does not pertain to a participant enrolled in the study, the information is not recorded on a CRF; however, a copy of the completed Vaccine SAE Report Form is maintained in the investigator site file.
Thank you all for the replies. After reading your post Juju7 it only further cemented my decision to not be around my brother. I'm making the 5.5 hr drive to drop off my mother ( he's driving her the rest of the way home to visit with her) and turning right around to head home. God bless you
I wouldnt let the vaccine get in the way of your relationships but if you feel its what's best for you then do what feels best. This document could cause fear in people and I dont believe fear should be the grounds for our decisions.
If this document if true it seems women are at risk and if you have woman in your life and plan on having children in your future then caution should be taken.
I'm convinced the people who get the covid vax are just as infectious as people who catch the actual virus naturally.
Considering its stored in your DNA and you shed 0.03 to 0.09 grams every hour of your skin and have a new outer skin layer after 4-6 weeks. I'm staying away from anyone vaccinated to avoid their potential covid shed for at least 6-8 weeks.
If this theory is correct ...anyone at a grocery store or gas station..etc..could be shedding.
They are - and neither masks nor social distancing does a damn thing about it.
It is likely they are transmitting the spike protein. A healthy immune system with the help of both HCQ and Ivermectin is your best defense.
https://skincaregeeks.com/how-long-does-it-take-to-shed-your-skin/#:~:text=Your%20skin%20cells%20are%20held%20together%20by%20desmosomes%2C,is%20between%200.03%20to%200.09%20grams%20every%20hour. Heres an article that goes in depth of the shedding process and time ranges.